Sit Investment Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-23,500
| Closed | -$1.94M | – | 544 |
|
2024
Q2 | $1.94M | Hold |
23,500
| – | – | 0.04% | 295 |
|
2024
Q1 | $2.05M | Hold |
23,500
| – | – | 0.05% | 294 |
|
2023
Q4 | $2.27M | Hold |
23,500
| – | – | 0.06% | 287 |
|
2023
Q3 | $2.08M | Hold |
23,500
| – | – | 0.06% | 284 |
|
2023
Q2 | $2.04M | Hold |
23,500
| – | – | 0.05% | 286 |
|
2023
Q1 | $2.29M | Hold |
23,500
| – | – | 0.06% | 279 |
|
2022
Q4 | $2.43M | Hold |
23,500
| – | – | 0.07% | 273 |
|
2022
Q3 | $1.99M | Hold |
23,500
| – | – | 0.06% | 278 |
|
2022
Q2 | $1.95M | Hold |
23,500
| – | – | 0.06% | 280 |
|
2022
Q1 | $1.81M | Hold |
23,500
| – | – | 0.05% | 306 |
|
2021
Q4 | $2.08M | Hold |
23,500
| – | – | 0.05% | 302 |
|
2021
Q3 | $1.82M | Hold |
23,500
| – | – | 0.05% | 307 |
|
2021
Q2 | $1.96M | Hold |
23,500
| – | – | 0.05% | 300 |
|
2021
Q1 | $1.77M | Hold |
23,500
| – | – | 0.05% | 310 |
|
2020
Q4 | $2.06M | Hold |
23,500
| – | – | 0.06% | 287 |
|
2020
Q3 | $1.79M | Hold |
23,500
| – | – | 0.05% | 290 |
|
2020
Q2 | $2.9M | Hold |
23,500
| – | – | 0.09% | 232 |
|
2020
Q1 | $1.99M | Buy |
23,500
+3,200
| +16% | +$270K | 0.08% | 262 |
|
2019
Q4 | $1.72M | Buy |
+20,300
| New | +$1.72M | 0.05% | 306 |
|